A weight loss drug called retatrutide has garnered significant interest, despite not being approved by the FDA. Some doctors are reportedly prescribing it anyway, and a black market for the drug appears to be thriving. The circumstances under which certain individuals may have accessed retatrutide are being investigated, with claims of special access being examined.